GluBio

GluBio is a biotech company focused on the development of molecular glue targeted protein degraders. The company aims to develop a new generation of molecular glue drugs targeting disease-causing proteins previously considered "undruggable." Currently, GluBio has established a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary high-activity molecule library.